|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號:R508170 |
| 產(chǎn)品名稱:Rifamycin B |
| 產(chǎn)品CAS:13929-35-6 |
| 規(guī)格含量:500mg |
| 產(chǎn)品價格:面議 |
| 聯(lián)系我們: |
|
|
|
|
|
| 產(chǎn)品詳細介紹 |
| 標準品編號: |
R508170 |
| 名稱: |
Rifamycin B |
| 別名: |
4-O-(Carboxymethyl)rifamycin; [(1,2-Dihydro-5,6,17,19,21-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-9-yl)oxy]acetic Acid 21-Acetate; Rifaximin EP Impurity B; |
| 雜質(zhì): |
Rifaximin EP Impurity B |
| CAS號: |
13929-35-6 |
| 分子式: |
C??H??NO?? |
| 外觀: |
Yellow to Orange Solid |
| 熔點: |
>161°C (dec.) |
| 分子量: |
755.8 |
| 儲存: |
Amber Vial, -20?C Freezer, Under Inert Atmosphere |
| 溶解度: |
DMSO (Slightly), Ethyl Acetate (Slightly), Methanol (Slightly) |
| 類別: |
Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應用: |
Rifamycin B (Rifaximin EP Impurity B) is a Rifamycin (R508200) derivative as antibacterial agent. |
| 參考文獻 |
|
|
|
|
|
|